Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.

Molecules and cells - 31 Dec 2019

Kang Chanhee

Abstract excerpt

Aging is the most important single risk factor for many chronic diseases such as cancer, metabolic syndrome, and neurodegenerative disorders. Targeting aging itself might, therefore, be a better strategy than targeting each chronic disease individually for enhancing human health. Although much should be achieved for completely understanding the biological basis of aging, cellular senescence is now believed to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aging
Share to Cellular Senescence
Share to Cytokines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Neoplasms

Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Share to Phenotype

Share to Telomeres, Telomerase, and Senescence

Source

Open in PubMed Open full text

Identifiers

PMID: 31838837
DOI: 10.14348/molcells.2019.0298
PMCID: PMC6939651

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.PMID 31838837Read ↗

Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging InterventionsSemantic proximity Read ↗

Targeting cellular senescence with senotherapeutics: senolytics and senomorphicsSemantic proximity Read ↗

Cellular senescence: a key therapeutic target in aging and diseasesSemantic proximity Read ↗

Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.Semantic proximity Read ↗

The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related DiseasesSemantic proximity Read ↗

Targeting senescent cells for a healthier longevity: the roadmap for an era of global agingSemantic proximity Read ↗

The Contribution of Physiological and Accelerated Aging to Cancer Progression Through Senescence-Induced InflammationSemantic proximity Read ↗

Senescence and senolysis in cancer: The latest findingsSemantic proximity Read ↗

Targeting senescent cells: approaches, opportunities, challengesSemantic proximity Read ↗

Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.Semantic proximity Read ↗

Cellular Senescence: A Translational Perspective.Semantic proximity Read ↗

Therapeutic strategies targeting cellular senescence for cancer and other diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.